top of page
Newsroom.
7NEWS Australia
15 Aug 2026
Media coverage
Australian Cancer Detection Breakthrough Risks Offshore Loss
News segment on OncoRes' cancer detection breakthrough, and the risk of the innovation moving offshore without local investment.
26 June 2026
Announcement
OncoRes Medical Awarded $3 Million CRC-P Grant to Advance Precision Prostate Cancer Surgery
A $3M Australian Government CRC-P grant to adapt OncoRes' Quantitative Micro-Elastography imaging technology for robotic prostatectomy and real-time biopsy evaluation.
The West Australian
4 June 2026
Media coverage
Triple-Whammy R&D Commercialisation Funding Budget Blow to Medical Innovators ‘Risks Driving Sector Offshore’
Coverage of R&D and commercialisation funding constraints risking medical-innovation companies relocating offshore, featuring OncoRes.
Business News
25 Feb 2026
Media coverage
OncoRes Raises $27m for Breast Cancer Tool
OncoRes secured $27M in private funding to advance its Elora™ handheld imaging device toward FDA approval.
16 Feb 2026
Announcement
First Patient Treated in MARGIN Clinical Study
First patient enrolled in the MARGIN clinical trial, evaluating Elora™'s use in breast-conserving surgery across 110+ patients and six Australian hospitals.
Medical Device Network
13 Feb 2026
Media coverage
OncoRes Medical Raises Funding to Advance Elora™ Clinical Development
A$27M private funding round to advance the Elora™ quantitative micro-elastography system for breast cancer surgery.
The West Australian
12 Feb 2026
Media coverage
WA Cancer Fighter's $30m Cash Injection
Nearly $30M raised to advance clinical trials for the Elora™ probe.
12 Feb 2026
Announcement
WA's OncoRes Secures Nearly $30m in Funding for Breast Cancer Detection Probe
AUD $27M private funding round closed to advance Elora™ clinical development, with comment from CEO Dr Katharine Giles.
14 Jan 2026
Team profile
In Conversation with Daniel Firth, Data & AI Manager at OncoRes Medical
Daniel Firth on leading OncoRes' data and AI programs, applying AI and computer vision in a regulated medical setting.
13 Oct 2025
Team profile
In Conversation with Imogen Boman, Clinical Research Associate at OncoRes Medical
Imogen Boman on her background in cancer care and biomedical research, and pursuing a Master of Public Health alongside her role.
Business News
19 Aug 2025
Media coverage
UWA Invests $1m in OncoRes Medical, as Company Enters Final Stretch of FDA Pitch
The University of Western Australia's first-ever investment in a spinout company — $1M into OncoRes to support its FDA approval push for Elora™.
24 June 2025
Team profile
In Conversation with Georgina Holbeche, QA/RA Manager at OncoRes Medical
Georgina Holbeche, an early-stage OncoRes employee, on now leading Quality Assurance and Regulatory Affairs.
9 News Australia
3 June 2025
Media coverage
New Technology Changing the Way Cancer Cells are Identified
Video news segment on OncoRes' technology for identifying cancer cells in real time during surgery.
Channel 9 News
27 Mar 2025
Media coverage
Cancer Revolution Technology Underway in Australia
TV segment featuring CEO Dr Katharine Giles demonstrating the Elora™ device at OncoRes' Perth HQ, including a patient perspective.
9 Aug 2024
Team profile
In Conversation with Wes Allen, Product Manager at OncoRes Medical
Dr Wes Allen, a founding team member and Product Manager since 2016, on the journey from research to product.
19 June 2024
Team profile
In Conversation with Bridget Ryan, CMO at OncoRes Medical
Dr Bridget Ryan, Deputy Chief Medical Officer, on OncoRes' patient-centred approach and patient-reported outcome measures.
13 June 2024
Team profile
In Conversation with Simon Graindorge, COO at OncoRes Medical
Dr Simon Graindorge, COO, discusses key 2024 milestones across clinical trials and regulatory progress.
Australian Financial Review
25 Mar 2024
Media coverage
‘More Than Mining’: WA Med-Tech Sector Message to Local Investors
Covers OncoRes' FDA breakthrough device designation and its growing team, as an example of WA's med-tech sector emerging beyond mining.
The West Australian
18 Aug 2023
Media coverage
Stemming the Tide of Our Best & Brightest
On CEO Dr Katharine Giles' appointment to the National Reconstruction Fund board, and her advocacy for keeping WA-developed IP and manufacturing onshore.
18 July 2023
Announcement
State Government Backs OncoRes Medical with Funding to Manufacture Digital Cancer Imaging
A $3M grant from the WA Government to manufacture OncoRes' cancer-imaging probe, bringing total funding raised to that point to $22M.
2 Nov 2022
Announcement
Media Release: First in-human use of OncoRes Medical’s cancer imaging system successful
Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research
MobiHealth News
24 May 2022
Media coverage
OncoRes Medical receives $12.5M in latest funding to pursue clinical trials
The company develops a breakthrough device for detecting residual cancer tissues.
Startup News
18 May 2022
Media coverage
OncoRes Medical secures $12.5m to advance breast cancer imaging system
Perth-based OncoRes Medical has announced $12.5 million in funding to advance its innovative imaging system that facilities real-time tumour assessment to assist surgeons in identifying and removing cancerous tissue such as breast cancer.
18 May 2022
Announcement
Media Release: Australian medical device company secures additional $12.5m to advance its breast ca
OncoRes Medical’s imaging system may be a game-changer for breast cancer surgeons
Business News
14 June 2021
Media coverage
Female Focus Leading Research
Female researchers and entrepreneurs have powered many of WA’s health care advancements
Medical Design and Outsourcing
14 May 2021
Media coverage
This imaging device could be a breakthrough for breast cancer treatment
OncoRes Medical’s system may detect cancer cells on a microscopic scale during a lumpectomy, potentially averting the need for a second breast cancer surgery.
3 May 2021
Announcement
Media Release: FDA grants Australian breast cancer innovation ‘Breakthrough Device Designation’ sta
OncoRes Medical has received ‘Breakthrough Device Designation’ from the U.S. Food and Drug Administration (FDA) to expedite development of its Quantitative Micro-Elastography (QME) Imaging System.
Australian Investment Council
.jpg)
9 Mar 2021
Media coverage
How Private Capital Works | Invest Week 2021
In the second part of the Invest Week digital series, Yasser is joined by Dr Kath Giles, CEO of OncoRes Medical. Kath has a unique background as a front-line medical practitioner, then making a move into another phase of her career by taking on a role in the investment sector.
22 Jan 2021
Announcement
Media Release: OncoRes Medical Receives $150,000 Funding Boost from Western Australian Government
Innovation and ICT Minister Dave Kelly today announced the McGowan Government will invest $150,000 in funding from the New Industries Fund into Western Australian-based medical device start-up OncoRes Medical to enhance R&D capability and create local jobs at their Nedlands-based facility.
29 Oct 2020
Announcement
Media Release: OncoRes Medical wins IGNITE Madness 2020
Perth-based medtech company, OncoRes Medical, has taken out the IGNITE Madness pitch competition in Houston, Texas, USA.
Startup News
29 July 2020
Media coverage
OncoRes Medical Wins $1M Biomed Grant
Perth-based medtech OncoRes Medical has been awarded $1 million funding as part of the Australian Government’s Medical Research Future Fund BioMedTech Horizons program, operated by MTPConnect.
20 July 2020
Announcement
Media Release: OncoRes Medical Awarded Prestigious Research Funding
Perth-based medtech company, OncoRes Medical, has been awarded $1 million funding as part of the Australian Government’s Medical Research Future Fund BioMedTech Horizons program, operated by MTPConnect.
15 Apr 2020
Announcement
Diagnostic Accuracy of Quantitative Micro-Elastography for Margin Assessment in Breast-Conserving Su
An optical imaging technology probes breast tissue elasticity to provide accurate assessment of tumor margin involvement in breast-conserving surgery.
AusBiotech
31 Oct 2019
Media coverage
Biotech leaders recognised by Industry Excellence Awards
OncoRes Medical, led by Dr Kath Giles, CEO and Managing Director, is an innovative medtech company that has made great strides in its short life since it was founded in late 2016.
MedTech Strategist
30 Oct 2019
Media coverage
OncoRes: Shedding Light on Breast Cancer Tumor Removal
The treatment of breast cancer today commonly entails repeat breast conserving surgeries due to imprecise methods of locating and measuring tumors during surgery.
Tech23
28 Oct 2019
Media coverage
Aussie Deeptech Companies Celebrated at Tech23 2019!
We’re still buzzing from Australia’s national celebration of deeptech innovation that was held in Sydney last week on Wednesday 23 October!
Smart Company
28 June 2019
Media coverage
Perth Startup Building Tech for Quicker Cancer Recovery Kicks Early Goal in Prestigious US Accelerator
Medtech startup OncoRes has been selected to take part in the prestigious MedTech Innovator Accelerator program in the US, becoming the first ever Aussie company in the final 24 and making waves within the first few weeks.
MedTech Innovator
24 June 2019
Media coverage
OncoRes Medical Takes Home $25,000 Value Award in First 2019 Competition
Leading Startup Awarded $25,000 Global Prize for its Intraoperative Handheld Imaging Tools to Identify and More Effectively Remove Tumor in Patients with Breast Cancer
12 June 2019
Announcement
Pitch@Palace Alumni View: Case Study
Australian start-up OncoRes was founded in 2016 to address an issue close to many people’s hearts – the treatment of breast cancer.
ABC News
13 Dec 2018
Media coverage
Perth Company Gains Global Recognition for 'Revolutionary' New Cancer Technology
Perth-based technology start-up OncoRes Medical has been internationally recognised for its work in attempting to improve the outcome of breast cancer surgery.
.jpg)
7 Nov 2018
Announcement
New Industries Fund: 2018 WA Innovator of the Year winners & finalists
The finalists of the 2018 program were showcased at the ceremony using videos of their innovations.
Business News
12 June 2018
Media coverage
Commercialising Medical Research
Australia’s medical technology, biotechnology and pharmaceutical sector is showing encouraging signs for future investors.
University of Western Australia
8 Mar 2018
Announcement
UWA Business Leaders Recognised in the 2018 40Under40 Awards
Katharine Giles is investment manager at Brandon Capital, a venture capital firm devoted to supporting Australian life sciences businesses.
University of Western Australia
.jpg)
22 Aug 2017
Media coverage
$6 million to commercialise EMS Research in new medical start-up
The Faculty of Engineering and Mathematical Sciences’ (EMS) Senior Research Fellow, Dr Brendan Kennedy, leads the cross-disciplinary research team behind the newly established Perth Company, OncoRes Medical.
bottom of page